A new breast cancer drug trialled at the Christie Hospital in Manchester could offer a lineline for women with the most aggressive form of the disease.
The drug, known as T-DM1, has been shown to increase the survival time of some patients by almost six months.
It also reduced side effects such as hair loss and gives sufferers a better quality of life.
More top news
The 'Talk Pants' Campaign is to encourage parents to talk to youngsters without scaring them about potential abuse
Shocking CCTV footage showing the moment a man stole cash from a 91-year-old woman.
The two men were jailed in June 2015 after HMRC investigators linked them to 109 illegal postal imports of cigarettes and tobacco